Transcutaneous immunization with a highly active form of XCL1 as a vaccine adjuvant using a hydrophilic gel patch elicits long-term CD8+ T cell responses

Authors:

Abstract
No abstract available
Funding Information
  • Ministry of Education, Culture, Sports, Science and Technology (S1411037)
  • Kindai University

This publication has 19 references indexed in Scilit: